Clinical Research Unit
The Clinical Research Unit (CRU) at the IHV supports clinical trials for complex infectious diseases. The research unit focuses on treating and preventing viral diseases, such as hepatitis B, hepatitis C and HIV, and emerging viruses like SARS-CoV-2, but also completes research on healthy volunteers. The CRU conducts industry-sponsored research studies, as well as investigator-initiated studies.
The CRU is comprised of a multidisciplinary team of physicians, nurse coordinators, research specialists and coordinators, a regulatory specialist, a biostatistician, a pharmacist, a research laboratory supervisor, and a phlebotomist, who help organize and implement the clinical trials. The research unit is on the first floor of the IHV with a six-room medical research suite that includes a waiting area, phlebotomy suite, negative pressure rooms, and easy access to the Division’s laboratories on the second and fifth floors of the IHV building. The CRU collaborates with other UMB researchers providing staff, space, and resources to support their clinical research.
Why Enroll in a Clinical Trial?
- Clinical trials test new treatments for HIV, hepatitis B, hepatitis C, COVID-19, and other viral diseases.
- During the trial you will be closely monitored by qualified health care professionals.
- Receive compensation for your time and effort.
- Your participation can be a valuable contribution to future research and the treatment of people with HIV, hepatitis B, hepatitis C, COVID-19, and other viral diseases.
IHV Clinical Trials Unit
Institute of Human Virology
725 W. Lombard Street
Baltimore, MD 21201
To enroll in a study call 410-706-1684.
The ASCEND Documentary: Patients, Providers, and Hepatitis C
An inside view of hepatitis C treatment in an urban community health care setting.